Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using theemail support widget if the problem persists.
The following section summarizes insights on Plus Therapeutics Inc's Avg EBITDA Margin Forecast (10y):
We've identified the following companies as similar to Plus Therapeutics Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Ten year average forecasted earnings before interest, taxes, depreciation and amortization (EBITDA) margin.
The chart above depicts the distribution of Avg EBITDA Margin Forecast (10y) for companies operating in the Healthcare Sector in the Developed economic region. Over 1,640 companies were considered in this analysis, and 1,579 had meaningful values. The average Avg EBITDA Margin Forecast (10y) of companies in the Sector is -106.0% with a standard deviation of 438.9%. Please note that Sector and Industry values may differ from other sources, as no adjustments have been made.
Plus Therapeutics Inc's Avg EBITDA Margin Forecast (10y) of -259.1% ranks in the 11.8% percentile for the Sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,645 |
| Included Constituents | 1,579 |
| Min | -3,877.8% |
| Max | 545.1% |
| Median | 15.9% |
| Mean | -106.0% |
| Standard Deviation | 438.9% |
You can find companies with similar Avg EBITDA Margin Forecast (10y) using this stock screener.